Bismuth subcitrate

From WikiMD's WELLNESSPEDIA

Bismuth Subcitrate is a chemical compound used in medicine, specifically in the treatment of peptic ulcer disease and Helicobacter pylori infection. It is also known as colloidal bismuth subcitrate (CBS) and De-Nol.

Chemical Properties[edit]

Bismuth subcitrate is a complex of bismuth and citrate ions. It is a white or almost white powder that is soluble in water. The chemical formula for bismuth subcitrate is C12H10Bi2O14.

Medical Uses[edit]

Bismuth subcitrate is used in the treatment of peptic ulcer disease and Helicobacter pylori infection. It works by coating the ulcer and protecting it from stomach acid. Bismuth subcitrate also has antimicrobial properties that help to kill Helicobacter pylori bacteria.

Side Effects[edit]

Common side effects of bismuth subcitrate include nausea, vomiting, and dark stools. In rare cases, it can cause a black tongue and black stools. Long-term use of bismuth subcitrate can lead to bismuth toxicity, which can cause symptoms such as skin reactions, neurologic abnormalities, and kidney damage.

Pharmacology[edit]

Bismuth subcitrate is not absorbed into the systemic circulation to a significant extent, which means that it has a low risk of systemic toxicity. It is excreted primarily in the feces.

History[edit]

Bismuth subcitrate was first used in medicine in the 18th century. It was originally used as a treatment for syphilis, but it is now primarily used in the treatment of peptic ulcer disease and Helicobacter pylori infection.

See Also[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.